Skip to main content

 Related scientific articles (all)

The impact of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) on the incidence of alopecia in patients with metastatic breast cancer (BC).

Authors : Eiger D, Wagner M, Pondé NF, Nogueira MS, Buisseret L, de Azambuja E
Year : 2020
Journal : 0
Pages : 1-3

PD-1 and PD-L1 inhibitors in oesophago-gastric cancers.

Authors : Akin Telli T, Bregni G, Camera S, Deleporte A, Hendlisz A, Sclafani F
Year : 2020
Journal : Cancer Lett
Volume : 469
Pages : 142-150

Effect of the COVID-19 pandemic on cancer treatment and research.

Authors : Saini KS, de Las Heras B, de Castro J, Venkitaraman R, Poelman M, Srinivasan G, Saini ML, Verma S, Leone M, Aftimos P, Curigliano G
Year : 2020
Journal : Lancet Haematol

Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial.

Authors : Lambertini M, Poggio F, Bruzzone M, Conte B, Bighin C, de Azambuja E, Giuliano M, De Laurentiis M, Cognetti F, Fabi A, Bisagni G, Durando A, Turletti A, Urracci Y, Garrone O, Puglisi F, Montemurro F, Ceppi M, Del Mastro L
Year : 2020
Journal : Int J Cancer
Volume : 147
Pages : 160-169

Use of granulocyte-colony stimulating factors in older patients: a review of recently published data.

Authors : Klastersky JA, Dal Lago L, Lalami Y
Year : 2020
Journal : Curr Opin Oncol

International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium.

Authors : Coens C, Pe M, Dueck AC, Sloan J, Basch E, Calvert M, Campbell A, Cleeland C, Cocks K, Collette L, Devlin N, Dorme L, Flechtner HH, Gotay C, Griebsch I, Groenvold M, King M, Kluetz PG, Koller M, Malone DC, Martinelli F, Mitchell SA, Musoro JZ, OConnor D, Oliver K, Piault-Louis E, Piccart-Gebhart M, Quinten C, Reijneveld JC, Schürmann C, Smith AW, Soltys KM, Taphoorn MJB, Velikova G, Bottomley A
Year : 2020
Journal : Lancet Oncol
Volume : 21
Pages : e83-e96

Early Detection of Metastatic Prostate Cancer Relapse on 68Ga-PSMA-11 PET/CT in a Patient Still Exhibiting Biochemical Response.

Authors : Plouznikoff N, Artigas C, Sideris S, Gil T, Flamen P
Year : 2020
Journal : Clin Nucl Med
Volume : 45
Pages : 81-82

Grey areas and evidence gaps in the management of rectal cancer as revealed by comparing recommendations from clinical guidelines.

Authors : Bregni G, Akin Telli T, Camera S, Baratelli C, Shaza L, Deleporte A, Moretti L, Bali MA, Liberale G, Hendlisz A, Sclafani F
Year : 2020
Journal : Cancer Treat Rev
Volume : 82
Pages : 101930

Cardiotoxicity of trastuzumab given for 12 months compared to shorter treatment periods: a systematic review and meta-analysis of six clinical trials.

Authors : Eiger D, Franzoi MA, Pondé N, Brandão M, de Angelis C, Schmitt Nogueira M, de Hemptinne Q, de Azambuja E
Year : 2020
Journal : ESMO Open
Volume : 5

Use of low-level laser therapy (LLLT) or photobiomodulation (PBM) for the management of the hand-foot syndrome (HSF) or palmo-plantar erythrodysesthesia (PPED) associated with cancer therapy.

Authors : Latifyan S, Genot MT, Fernez B, Scharll MF, Klastersky JA
Year : 2020
Journal : Support Care Cancer
Volume : 28
Pages : 3287-3290

The lack of selection criteria for surgery in patients with non-colorectal non-neuroendocrine liver metastases.

Authors : Bohlok A, Lucidi V, Bouazza F, Daher A, Germanova D, Van Laethem JL, Hendlisz A, Donckier V
Year : 2020
Journal : World J Surg Oncol
Volume : 18
Pages : 106

Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis.

Authors : Rescigno P, Dolling D, Conteduca V, Rediti M, Bianchini D, Lolli C, Ong M, Li H, Omlin AG, Schmid S, Caffo O, Zivi A, Pezaro CJ, Morley C, Olmos D, Romero-Laorden N, Castro E, Saez MI, Mehra N, Smeenk S, Sideris S, Gil T, Banks P, Sandhu SK, Sternberg CN, De Giorgi U, de Bono JS
Year : 2020
Journal : Eur Urol Oncol
Volume : 3
Pages : 176-182

Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy.

Authors : Craciun L, de Wind R, Demetter P, Lucidi V, Bohlok A, Michiels S, Bouazza F, Vouche M, Tancredi I, Verset G, Garaud S, Naveaux C, Galdon MG, Gallo KW, Hendlisz A, Derijckere ID, Flamen P, Larsimont D, Donckier V
Year : 2020
Journal : BMC Cancer
Volume : 20
Pages : 135

Early prediction of neoadjuvant treatment outcome in locally advanced breast cancer using parametric response mapping and radial heterogeneity from breast MRI.

Authors : Drisis S, El Adoui M, Flamen P, Benjelloun M, Dewind R, Paesmans M, Ignatiadis M, Bali M, Lemort M
Year : 2020
Journal : J Magn Reson Imaging
Volume : 51
Pages : 1403-1411

Metastatic breast cancer and pseudocirrhosis: an unknown clinical entity.

Authors : Engelman D, Moreau M, Lepida A, Zaouak Y, Paesmans M, Awada A
Year : 2020
Journal : ESMO Open
Volume : 5

Analysis of inflammatory markers and hormones in old cancer patients: A descriptive study.

Authors : De Breucker S, Luce S, Njemini R, Bautmans I, Decoster L, Mets T, Pepersack T
Year : 2020
Journal : Exp Gerontol
Volume : 130
Pages : 110787

Adjuvant chemotherapy for gastrointestinal cancers: we can do much better.

Authors : Sclafani F, Hendlisz A
Year : 2020
Journal : Curr Opin Oncol

The Impact of Thyroid Disorders on Clinical Pregnancy Outcomes in a Real-World Study Setting.

Authors : Sitoris G, Veltri F, Kleynen P, Cogan A, Belhomme J, Rozenberg S, Pepersack T, Poppe K
Year : 2020
Journal : Thyroid
Volume : 30
Pages : 106-115

ESMO Clinical Research Observatory (ECRO): improving the efficiency of clinical research through rationalisation of bureaucracy.

Authors : Perez-Gracia JL, Awada A, Calvo E, Amaral T, Arkenau HT, Gruenwald V, Bodoky G, Lolkema MP, Di Nicola M, Penel N, Vera R, Sanmamed MF, Douillard JY
Year : 2020
Journal : ESMO Open
Volume : 5

Prognostic value of a three-scale grading system based on combining molecular imaging with <sup>68</sup>Ga-DOTATATE and <sup>18</sup>F-FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasias.

Authors : Karfis I, Marin G, Levillain H, Drisis S, Muteganya R, Critchi G, Taraji-Schiltz L, Guix CA, Shaza L, Elbachiri M, Mans L, Machiels G, Hendlisz A, Flamen P
Year : 2020
Journal : Oncotarget
Volume : 11
Pages : 589-599